is a 4-year FP7 European Union funded Project which has been awarded a total budget of 11.9 million €, led by Coordinator Prof. Elena Cattaneo – University of Milan and Deputy Coordinator Prof. Anders Björklund – Lund University. NeuroStemcell, which comprises 13 academic partners and 2 SMEs and 1 Research Enterprise from 6 European countries and the United States of America, is formed to create a world-leading consortium that can develop stem cell based therapies for Parkinson´s disease and Huntington´s disease toward clinical application...Read more »
The National Geographic blog reports about an exciting development of NeuroStemcell research
NeuroStemcell develops a new method to transform pluripotent stem cells into neurons for studying Huntington's Disease
10th December 2012
New position available for a postdoctoral fellow working in stem cell biology
September 11th - 13th, 2012
Designing phase I clinical trial with transplantation of candidate cell line in Parkinson’s disease
September 15th - 21st, 2012
REGISTRATION CLOSING for the eigth Hydra Summer School!!